SFI
MRNA icon

Siemens Fonds Invest’s Moderna MRNA Stock Holding History

Siemens Fonds Invest’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,571
Closed -$101K – 570
2025
Q1 		$101K Sell
3,571
-3,509
-50% -$125K 0.01% 534
2024
Q4 		$279K Sell
7,080
-2,020
-22% -$96.5K 0.02% 387
2024
Q3 		$385K Sell
9,100
-2,020
-18% -$185K 0.03% 313
2024
Q2 		$1.32M Buy
11,120
+86
+0.8% +$10.9K 0.1% 198
2024
Q1 		$1.18M Sell
11,034
-7,925
-42% -$799K 0.09% 206
2023
Q4 		$1.89M Buy
18,959
+1,746
+10% +$147K 0.15% 183
2023
Q3 		$1.78M Buy
17,213
+10,462
+155% +$1.17M 0.18% 145
2023
Q2 		$816K Hold
6,751
– – 0.08% 191
2023
Q1 		$1.04M Sell
6,751
-37
-0.5% -$6.1K 0.11% 175
2022
Q4 		$1.22M Sell
6,788
-589
-8% -$96.3K 0.12% 161
2022
Q3 		$872K Sell
7,377
-352
-5% -$53.4K 0.1% 179
2022
Q2 		$1.1M Sell
7,729
-29
-0.4% -$4.14K 0.12% 166
2022
Q1 		$1.34M Hold
7,758
– – 0.11% 167
2021
Q4 		$1.95M Buy
7,758
+2,681
+53% +$784K 0.13% 154
2021
Q3 		$1.95M Buy
+5,077
New +$1.87M 0.13% 144

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Siemens Fonds Invest's MRNA Position: Q2 2025 in Review

Siemens Fonds Invest sold out of Moderna (MRNA) in Q2 2025, closing a stake of 3,571 shares — an estimated $101K sold.

Siemens Fonds Invest first reported a position in MRNA in Q3 2021 and held it in 15 quarters. The position peaked at $1.95M in Q3 2021. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Siemens Fonds Invest reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Siemens Fonds Invest sold 3,571 Moderna shares in Q2 2025, an estimated $101K.
  • Siemens Fonds Invest first reported a position in Moderna in Q3 2021 and held it in 15 quarters.
  • Siemens Fonds Invest's Moderna position peaked at $1.95M in Q3 2021.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Siemens Fonds Invest's 13F filing for Q2 2025, filed 14 Aug 2025.